Simple gene technique changes sex of a mouse
By Steve Connor,
The Independent
| 12. 11. 2009
From Minnie to Mickey (and all they did was turn off a gene)
The battle of the sexes is a never-ending war waged within ourselves
as male and female elements of our own bodies continually fight each
other for supremacy. This is the astonishing implication of a
pioneering study showing that it is possible to flick a genetic switch
that turns female ovary cells into male testicular tissue.
For
decades, the battle of the sexes has been accepted by biologists as a
real phenomenon with males and females competing against each other -
when their interests do not coincide - for the continued survival of
their genes in the next generation. Now scientists have been able to
show that a gender war is constantly raging between the genes and cells
of one individual.
One of the great dogmas of biology is that
gender is fixed from birth, determined by the inheritance of certain
genes on the X and Y sex chromosomes. But this simplistic idea has been
exploded by the latest study, which demonstrated that fully-developed
adult females can undergo a partial sex change following a genetic
modification to a single gene.
The...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...